Literature DB >> 1552747

Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region.

S Fichelson1, F Dreyfus, R Berger, J Melle, C Bastard, J M Miclea, S Gisselbrecht.   

Abstract

The Evi-1 zinc-finger protein gene is normally not expressed in hematopoietic cells. However, high Evi-1 mRNA expression has been reported in mouse myeloblastic leukemias, due to transcriptional activation by proviral integration in either the Fim-3 or Evi-1 loci. The human Evi-1 gene is located on chromosome 3q24-q28. In this paper three examples are presented of human acute myelogenous leukemias presenting common characteristics: (i) high Evi-1 mRNA expression; (ii) chromosomal abnormalities t(3;3)(q21;q26) or inv(3;3)(q21-22;q26); and (iii) high platelet counts and dystrophic megakaryocytes. Thirty-four other patients with hematological malignancies, among which 11 had chromosomal rearrangements in the 3q24-q28 region did not exhibit such abnormalities. Of the 13 permanent hemopoietic cell lines tested, Evi-1 RNA expression was found in HEL and K-562 cell lines. Weak Evi-1 expression was also seen in fibroblasts and lung cells. This expression was affected neither in skin cells from a patient with a 3q27 constitutional translocation nor in a lung epithelioma cell line containing an excess of chromosome 3 long arm. Ectopic strong expression of Evi-1 in human leukemias could define an uncommon subclass of acute myelogenous leukemias with translocations involving the 3q25-28 chromosomal domain and abnormal megakaryopoiesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552747

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

1.  Can a high platelet count be responsible for diabetes insipidus in acute myelogenous leukemia with monosomy 7 and inversion 3 (q21q26)?

Authors:  Mehmet Sonmez; Nergiz Erkut; T Songul Tat; Figen Celep; Umit Cobanoglu; H Onder Ersoz
Journal:  Int J Hematol       Date:  2009-08-12       Impact factor: 2.490

2.  Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.

Authors:  S Fears; C Mathieu; N Zeleznik-Le; S Huang; J D Rowley; G Nucifora
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

3.  Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.

Authors:  B L Kreider; S H Orkin; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

4.  Molecular cytogenetic analyses of HIG, a novel human cell line carrying t(1;3)(p36.3;q25.3) established from a patient with chronic myelogenous leukemia in blastic crisis.

Authors:  Noriko Hosoya; Seishi Ogawa; Tohru Motokura; Akira Hangaishi; Lili Wang; Ying Qiao; Yasuhito Nannya; Mieko Kogi; Hisamaru Hirai
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

5.  Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.

Authors:  T Tanaka; K Mitani; M Kurokawa; S Ogawa; K Tanaka; J Nishida; Y Yazaki; Y Shibata; H Hirai
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

Review 6.  Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia.

Authors:  R Stasi; C G Taylor; A Venditti; G Del Poeta; G Aronica; C Bastianelli; M D Simone; F Buccisano; M C Cox; A Bruno
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

7.  Mutant N-RAS induces erythroid lineage dysplasia in human CD34+ cells.

Authors:  R L Darley; T G Hoy; P Baines; R A Padua; A K Burnett
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

8.  New functions for ecotropic viral integration site 1 (EVI1), an oncogene causing aggressive malignant disease.

Authors:  Rotraud Wieser
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

9.  EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.

Authors:  Anna Rommer; Birgit Steinmetz; Friederike Herbst; Hubert Hackl; Petra Heffeter; Daniela Heilos; Martin Filipits; Katarina Steinleitner; Shayda Hemmati; Irene Herbacek; Ilse Schwarzinger; Katharina Hartl; Pieter Rondou; Hanno Glimm; Kadin Karakaya; Alwin Krämer; Walter Berger; Rotraud Wieser
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.